Synonyms: C188-9 [2] | TTI 101 | TTI101
Compound class:
Synthetic organic
Comment: TTI-101(formerly C188-9) is an orally bioavailable STAT3 transcription factor inhibitor. It blocks the tyrosine residue phosphorylation by Janus kinase (JAK) that mediates STAT3 activation, leading to downregulation of STAT3-mediated gene expression. This mechanism of action is considered as a valid approach for the treatment of inflammation, fibrosis, and a range of cancers [1,3].
|
|
Bioactivity Comments |
Antiproliferative activity against human cancer cell lines has been demonstrated in vitro [2]. The parental molecule of TTI-101, C188, inhibits binding (measured by SPR) of a phospho-tyrosine peptide substrate to STAT3 with an IC50 of 73 μM [4] |
Selectivity at other protein targets | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|